Babatunde Otulana

Babatunde Adekunle Otulana is currently the Senior Independent Non-Executive Director at Allergy Therapeutics Plc, the Director at Flow Pharma, Inc., the Associate Clinical Professor at the University of California, Davis, a Member of the United Nations Environment Programme, and the Chief Medical Officer at Veloxis Pharmaceuticals, Inc. He previously served as the Non-Executive Director at Revolo Biotherapeutics Ltd., the Chief Medical Officer & SVP-Development at Aradigm Corp., the Chief Medical Officer & Senior Vice President at Aerovance, Inc., Mallinckrodt Plc, and Mallinckrodt Pharmaceuticals Ltd., and the Senior VP-Clinical Development & Medical Affairs at Boehringer Ingelheim Pharmaceuticals, Inc. He also worked as a Medical Officer & Clinical Team Leader at the Center for Drug Evaluation & Research.
Dr. Otulana holds a doctorate degree from the University of Ibadan.